Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
7.24
+0.06 (0.84%)
Jul 16, 2025, 4:00 PM - Market closed
Capricor Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts that cover Capricor Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $24.75, which forecasts a 241.85% increase in the stock price over the next year. The lowest target is $12 and the highest is $35.
Price Target: $24.75 (+241.85%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Capricor Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 5 | 5 |
Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 7 | 7 | 7 | 8 | 8 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Roth Capital | Roth Capital | Strong Buy Maintains $31 → $12 | Strong Buy | Maintains | $31 → $12 | +65.75% | Jul 14, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $77 → $24 | Strong Buy | Maintains | $77 → $24 | +231.49% | Jul 11, 2025 |
B. Riley Securities | B. Riley Securities | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +190.06% | Jun 26, 2025 |
Jones Trading | Jones Trading | Strong Buy Maintains $40 → $29 | Strong Buy | Maintains | $40 → $29 | +300.55% | Jun 25, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $77 | Strong Buy | Reiterates | $77 | +963.54% | Jun 24, 2025 |
Financial Forecast
Revenue This Year
123.36M
from 22.27M
Increased by 453.92%
Revenue Next Year
102.08M
from 123.36M
Decreased by -17.25%
EPS This Year
-0.97
from -1.15
EPS Next Year
-0.31
from -0.97
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 244.1M | 190.6M | 258.8M | ||
Avg | 123.4M | 102.1M | 131.9M | ||
Low | 7.7M | 25.4M | 53.6M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 996.2% | 54.5% | 153.6% | ||
Avg | 453.9% | -17.3% | 29.2% | ||
Low | -65.2% | -79.4% | -47.5% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 1.80 | 1.44 | 1.74 | ||
Avg | -0.97 | -0.31 | 0.38 | ||
Low | -2.07 | -1.35 | -0.73 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.